通过结合基于纳米颗粒蛋白冠的样品制备和毛细管区带电泳-串联质谱法进行高通量血浆/血清蛋白质组学研究。
High-throughput plasma/serum proteomics by coupling nanoparticle protein corona-based sample preparation and capillary zone electrophoresis-tandem mass spectrometry.
作者信息
Wang Qianyi, Sadeghi Seyed Amirhossein, Fang Fei, Zheng Dejin, Luo Chenxiang, Gao Guangyao, Wang Qianjie, Gu Bin, Sun Liangliang
机构信息
Department of Chemistry, Michigan State University, East Lansing, Michigan, 48824, USA.
Department of Obstetrics Gynecology and Reproductive Biology, Institute for Quantitative Health Science and Engineering, Michigan State University, East Lansing, Michigan, 48824, USA.
出版信息
Anal Methods. 2025 Jul 29. doi: 10.1039/d5ay00721f.
A high-throughput workflow for bottom-up proteomics (BUP) of human plasma using capillary zone electrophoresis-tandem mass spectrometry (CZE-MS/MS) and nanoparticle protein corona-assisted sample preparation is presented. The streamlined approach enabled the identification and quantification of hundreds of proteins from plasma/serum samples in 3.5 hours from sample to data. Nanoparticles with varied physiochemical properties studied in this work captured different pools of the plasma/serum proteome in the protein coronas, and the protein corona-based sample preparation approach enabled the measurement of low-abundance proteins compared to the approach without nanoparticles. Applying this high-throughput workflow to serum samples of a mouse NUT carcinoma (NC) cancer model allowed the determination of differentially expressed serum proteins between NC bearing mice and healthy controls. By comparing our quantitative proteomics data with published transcriptomics data, we revealed a handful of potential serum protein biomarkers of NC cancer (, secreted phosphoprotein 1, SPP1). We expect this high-throughput workflow, with additional improvement in the speed of the mass spectrometer, will be useful for advancing the discovery of new protein biomarkers of diseases (, cancer) using plasma/serum samples.
本文介绍了一种用于人血浆的自下而上蛋白质组学(BUP)的高通量工作流程,该流程采用毛细管区带电泳-串联质谱(CZE-MS/MS)和纳米颗粒蛋白冠辅助样品制备。这种简化的方法能够在3.5小时内从样品到数据,对血浆/血清样品中的数百种蛋白质进行鉴定和定量。在这项工作中研究的具有不同物理化学性质的纳米颗粒在蛋白冠中捕获了血浆/血清蛋白质组的不同部分,与没有纳米颗粒的方法相比,基于蛋白冠的样品制备方法能够测量低丰度蛋白质。将这种高通量工作流程应用于小鼠NUT癌(NC)癌症模型的血清样品,能够确定荷瘤小鼠和健康对照之间差异表达的血清蛋白。通过将我们的定量蛋白质组学数据与已发表的转录组学数据进行比较,我们发现了一些NC癌症的潜在血清蛋白生物标志物(如分泌磷蛋白1,SPP1)。我们预计,随着质谱仪速度的进一步提高,这种高通量工作流程将有助于利用血浆/血清样品推进疾病(如癌症)新蛋白质生物标志物的发现。